Brett Giroir is the founder of Altesa. Altesa has raised $79M in total funding. Latest round: Series B. Backed by Forbion, Sanofi, Medicxi.
Dr. Brett P. Giroir is the CEO and Executive Chairman of Altesa BioSciences, a clinical-stage biopharmaceutical company developing antiviral drugs for viral respiratory infections. He previously served as the U.S. Assistant Secretary for Health and Acting FDA Commissioner, and is a former Trump administration official and an Admiral in the U.S. Public Health Service.
Full founder directory · Investor directory · Company funding database · Fundraising library